30
Participants
Start Date
March 1, 2026
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2029
BCMA-TGFβ CAR-T cells (0.50 x 10^6 cells/kg)
This is dose level 0 (de-escalation).
BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
This is dose level 1, the starting dose.
BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg)
This is dose level 2.
BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg)
This is dose level 3.
Maximum tolerated dose
The maximum tolerated dose is yet to be determined.
Medical College of Wisconsin
OTHER